A special thanks to Aryan for finishing his work experience at PEAK.
And a true blue PEAK send off on his final day (see pic below).
On another note…
Have you been following the cannabis space lately?
Federal parliament could override state laws to legalise recreational marijuana use, according to new constitutional advice obtained by the Greens.
Click here to read more.
Certainly bodes well for our portfolio companies ECS, IRX, and others.
Across Markets…
A big rally in iron ore, coal, lithium and oil producers helped the benchmark S&P/ASX 200 Index close 0.4 per cent higher on Tuesday.
The materials sector added 2.4 per cent with heavyweight BHP up 2.8 per cent and Fortescue Metals soaring 5.5 per cent as iron ore futures traded in Singapore clawed back losses.
A mini-rebound in oil prices also helped Woodside and Santos post strong gains.
The interest rate sensitive real estate sector was the worst performer as longer-dated bond yields continued to rise.
Westfield-owner Scentre lost 2.3 per cent, with Goodman Group down 2.5 per cent.
Santos is considering a $US1.4 billion ($2.16 billion) bid for a 5 per cent stake in PNG LNG project from Papua New Guinea’s national oil and gas company Kumul Petroleum.
Source: AFR
InhaleRx (ASX: IRX) has beefed up its board and management as it readies for clinical trials of its cannabinoid-based inhaled therapies.
The company has appointed existing executive director Darryl Davies as chief executive officer to lead its next development phase in their pursuit of acquiring New Drug Approvals (NDA’s) with the US Food and Drug Administration (FDA).
The changes are in preparation for operational execution across two clinical trial programmes investigating the role of targeted dose inhaled cannabinoids to address unmet clinical needs for patients suffering with panic disorder and complex regional pain syndrome.
Mr Davies joined InhaleRx as an executive director in July last year and has more than 17 years’ experience in psychology, harm minimisation and healthcare commercialisation.
Source: SmallCaps
Sector: Uranium
Deal Type: IPO
Raise Amount: $7.5M
Latest Entry Price: $0.20
Today’s Price Change: $0.345 +2.99%
Sector: Energy
Deal Type: Placement
Raise Amount: $933K & $5.8M
Latest Entry Price: $0.08 with a 1:2 Listed Option
Today’s Price Change: $0.03 +3.45%
Company: Volt Resources Ltd. (ASX:VRC)
Sector: Battery Metals
Deal Type: Placement
Raise Amount: $5.75M
Latest Entry Price: $0.011
Today’s Price Change: $0.024 +9.09%
Company: Castle Minerals Ltd. (ASX:CDT)
Sector: Battery Metals/Base Metals
Deal Type: Placement
Raise Amount: $1.52M
Latest Entry Price: $0.03 with a 1:3 CDTOA
Today’s Price Change: $0.026 +4.00%
Company: Latrobe Magnesium Ltd. (ASX:LMG)
Sector: Magnesium
Deal Type: Placement
Raise Amount: $3M & $11.5M
Latest Entry Price: $0.10 with a 1:4 LMGO
Today’s Price Change: $0.081 -1.22%
Company: Metgasco Ltd. (ASX:MEL)
Sector: Energy
Deal Type: Underwritten Rights Offer
Raise Amount: $4.58M
Latest Entry Price: $0.025 with 1:3 listed option
Today’s Price Change: $0.025 +8.70%
Company: Askari Metals Ltd (ASX:AS2)
Sector: Mining
Deal Type: IPO
Raise Amount: $5.7M
Latest Entry Price: $0.35 with a 1:3 AS2O
Today’s Price Change: $0.275 Unchanged
Company: Tymlez Ltd (ASX:TYM)
Sector: Blockchain
Deal Type: IPO/On-market purchase
Raise Amount: $13.3M
Latest Entry Price: $0.01
Today’s Price Change: $0.024 +4.35%
Company: iCandy (ASX:ICI)
Sector: Gaming & Digital Advertising
Deal Type: Placement
Raise Amount: $1.25M
Latest Entry Price: $0.02 with a 1:1 ICIOB
Today’s Price Change: $0.068 Unchanged
Sector: Fintech
Deal Type: Placement
Raise Amount: $1.5M
Latest Entry Price: $0.015 with a 1:2 FFGOA
Today’s Price Change: $0.025 Unchanged
Company: Lobe Sciences (CSE:LOBE)
Sector: Medtech
Deal Type: Pre-IPO
Raise Amount: $1.5M
Latest Entry Price: $0.08 with a 1:2 Option
Today’s Price Change: $0.12 +4.35%
Company: Paradigm Biopharma (ASX:PAR)
Sector: Biopharma
Deal Type: IPO Cornerstone
Raise Amount: $1M+
Latest Entry Price: $0.35
Today’s Price Change: $1.215 -2.02%
Sector: Satellite Communication
Deal Type: Placement
Raise Amount: $5.3M & $5M
Latest Entry Price: $0.44 with a 1:4 Option
Today’s Price Change: $0.26 +10.64%
Company: Nanollose Limited (ASX:NC6)
Sector: Biomaterials
Deal Type: Placement
Raise Amount: $2.85M
Latest Entry Price: $0.10 with a 1:2 NC6OA
Today’s Price Change: $0.060 Unchanged
Company: ReNu Energy Limited (ASX:RNE)
Sector: Energy
Deal Type: Placement
Raise Amount: $1.46M
Latest Entry Price: $0.09 with a 1:4 RNEO
Today’s Price Change: $0.039 Unchanged
Company: Cipherpoint Limited (ASX:CPT)
Sector: Cybersecurity
Deal Type: Placement
Raise Amount: $2.9M
Latest Entry Price: $0.005 with a 1:1 Listed Option
Today’s Price Change: $0.004 Unchanged
Company: Metals Australia Limited (ASX:MLS)
Sector: Lithium/Graphite
Deal Type: Placement
Raise Amount: $7.8M
Latest Entry Price: $0.078 with 1:1 MLSOD
Today’s Price Change: $0.044 +4.76%
Sector: Mining
Deal Type: Underwritten Rights Offer
Raise Amount: $2.98M
Latest Entry Price: $0.24 with a 1:1 BOAOA
Today’s Price Change: $0.125 -7.41%
Company: BBX Minerals Ltd (ASX:BBX)
Sector: Mining
Deal Type: Placement
Raise Amount: $2.1M
Latest Entry Price: $0.082 with a 1:1 BBXOA
Today’s Price Change: $0.067 Unchanged
Sector: Consumer Discretionary
Deal Type: Seed, Bridging and IPO
Raise Amount: $10M
Latest Entry Price: $0.08 with a 1:1 CLBO
Sector: CBD
Raise Amount: $5M
Latest Entry Price: $0.022 with a 1:2 AVEO
Today’s Price Change: $0.011 Unchanged
Sector: Cannabis and Hemp
Deal Type: Placement
Raise Amount: $6.6M
Latest Entry Price: $0.033 with 1:2 ECSO
Today’s Price Change: $0.022 +4.76%
If you would like more information on future Peak deals, please don’t hesitate to get in touch.
Peak accepts no responsibility for any views expressed and marketing material contained in this email except where the message specifically states otherwise and the sender is authorised to state them to be the views of Peak. Information provided in this email is general advise only and does take account your objectives, financial situation or needs. Before acting on any advice in this email, Peak recommends that you consider whether it is appropriate for your circumstances. If this email contains reference to any financial products, you should obtain the current Product Disclosure Statement (PDS) or other disclosure documents for the particular products and consider this information before making any decisions regarding the products. The Financial Services Guide (FSG) can be found at www.peakassetmanagement.com.au or by telephoning Peak on 1300 304 460
